InvestorsHub Logo
Followers 43
Posts 6960
Boards Moderated 0
Alias Born 03/18/2016

Re: RobotDroid post# 30225

Thursday, 03/26/2020 2:15:55 PM

Thursday, March 26, 2020 2:15:55 PM

Post# of 43747
We are also mentioned here, about 3/4 thru it...https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/
If you do not feel like scrolling, here is what it says:
CEL-SCI
CEL-SCI is developing immunotherapy against COVID-19 using its proprietary LEAPS peptide technology, which utilises conserved areas of the coronavirus proteins to generate T-cell responses and reduce viral load. The technology can also be used to develop immunotherapeutic peptides with both antiviral and anti-inflammatory properties.

The peptides developed using this technology can help in reducing tissue damage from inflammation caused due to lung infection, which is a major cause of mortality in elderly patients.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News